Celecoxib for the Prevention of Sporadic Colorectal AdenomasMonica M. Bertagnolli, Ernest T. Hawk, Craig Eagle et al.|New England Journal of Medicine|2006Cited by 1k
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib TrialMonica M. Bertagnolli, Craig Eagle, Ann G. Zauber et al.|Cancer Prevention Research|2009Cited by 193
AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human TrialM. Scott Harris, Barbara S. Fox, Sally Kennedy et al.|Journal of Crohn s and Colitis|2016Cited by 75